Autonomous parvoviruses are small, single-stranded DNA viruses which are incapable of inducing resting cells to enter S-phase and thus replicate exclusively in dividing cell populations. They show complex tissue specificities which operate at multiple steps in the infectious process, and the proposed research is aimed at understanding the molecular basis of these tropisms and the mechanisms by which parvoviruses initiate productive or abortive life cycles in their hosts. While many cell types share appropriate cell surface receptors, viral gene expression is restricted to a subset of cells which express a specific, as yet unidentified, intracellular receptor capable of interacting with a mutable element on the viral capsid termed the allotropic determinant. The crystal structure of the lymphotropic variant of minute virus of mice (MVMi) will be completed, and the structures of both virions and empty capsids will be compared with host range variants differing by just one or two amino acids. Capsid structure will be probed genetically and serologically to explore cell ligands and the disposition of elements disordered in the crystals. Strategies to identify the high abundance, high affinity viral receptor on the surface of human T-cells will be developed. Monoclonal antibodies raised against virions will be screened for their ability to recognize the allotropic determinant, in an attempt to place this on the structural map. Antibodies directed against specific features on the virion surface will be electroporated into the cytosol of target cells, in order to explore the process of penetration. Non-replicative functions of NS1, the major viral non-structural protein, will be studied by analyzing non-cytostatic cytocidal mutants. parameters of the growth of MVMi in cycling and quiescent human T-cells will be examined, so as to determine the fate and state of the viral genome in non-cycling cells. These studies will exploit the recent development of MVM-Tar, a chimeric MVMi derivative which is dependent upon the HIV-1 tat transactivator protein for its own replication. The roles of the NS proteins in the synthesis and assembly of the capsid proteins will be studied. A random sequence PCR technique will be employed to determine the consensus DNA binding site for NS1. The importance of this NS1:DNA interaction in the assembly of viral nucleoprotein and in transcriptional transactivation of the viral P38 promoter will be assessed. The knowledge gained will be used to construct a synthetic promoter for the development of cell lines for packaging MVM-based expression vectors. New mutants, expressor cell lines and recombinant vaccinia viruses will be used to explore the involvement of the NS2 family of minor NS proteins in the synthesis and assembly of capsids. Finally, viral recombinants will be constructed with dual utility, both as transient expression vectors for human cells, and as tools for dissecting the viral packaging mechanism. Since transformed cells are exceptionally susceptible to killing by parvoviruses, understanding their complex target cell specificity, the means whereby the usurp cellular control and how they generate infectious particles, may allow development of these viruses as rugged, potentially injectable vectors for targeting disseminated transformed cells in neoplastic disease.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA029303-18
Application #
2633734
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Cole, John S
Project Start
1981-01-01
Project End
2000-12-31
Budget Start
1998-01-01
Budget End
1998-12-31
Support Year
18
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Yale University
Department
Pathology
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Forbes, Neil S; Coffin, Robert S; Deng, Liang et al. (2018) White paper on microbial anti-cancer therapy and prevention. J Immunother Cancer 6:78
Marr, Matthew; D'Abramo, Anthony; Pittman, Nikea et al. (2018) Optimizing the Targeting of Mouse Parvovirus 1 to Murine Melanoma Selects for Recombinant Genomes and Novel Mutations in the Viral Capsid Gene. Viruses 10:
Pittman, Nikéa; Misseldine, Adam; Geilen, Lorena et al. (2017) Atomic Resolution Structure of the Oncolytic Parvovirus LuIII by Electron Microscopy and 3D Image Reconstruction. Viruses 9:
Meir, Chen; Mincberg, Michal; Rostovsky, Irina et al. (2017) The MVMp P4 promoter is a host cell-type range determinant in vivo. Virology 506:141-151
Subramanian, Suriyasri; Organtini, Lindsey J; Grossman, Alec et al. (2017) Cryo-EM maps reveal five-fold channel structures and their modification by gatekeeper mutations in the parvovirus minute virus of mice (MVM) capsid. Virology 510:216-223
Nakaya, Yuki; Stavrou, Spyridon; Blouch, Kristin et al. (2016) In Vivo Examination of Mouse APOBEC3- and Human APOBEC3A- and APOBEC3G-Mediated Restriction of Parvovirus and Herpesvirus Infection in Mouse Models. J Virol 90:8005-12
Mihaylov, Ivailo S; Cotmore, Susan F; Tattersall, Peter (2014) Complementation for an essential ancillary non-structural protein function across parvovirus genera. Virology 468-470:226-37
Vollmers, Ellen M; D'Abramo Jr, Anthony; Cotmore, Susan F et al. (2014) Genome sequence of tumor virus x, a member of the genus protoparvovirus in the family parvoviridae. Genome Announc 2:
Halder, Sujata; Cotmore, Susan; Heimburg-Molinaro, Jamie et al. (2014) Profiling of glycan receptors for minute virus of mice in permissive cell lines towards understanding the mechanism of cell recognition. PLoS One 9:e86909
Cotmore, Susan F; Agbandje-McKenna, Mavis; Chiorini, John A et al. (2014) The family Parvoviridae. Arch Virol 159:1239-47

Showing the most recent 10 out of 64 publications